Home Biosimilar Antibodies Others Others Bepranemab (Anti-Tau)
For research use only. Not for use in humans.

Bepranemab (Anti-Tau)

Synonyms: DDPAC， FTDP-17

Bepranemab (Anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that targets to a central tau epitope (amino acids 235-250).It can be used for Alzheimer’s disease (AD) research. MW :145.92 KD.

Bepranemab (Anti-Tau)

Quality Control

  • Cited in Nature Medicine for its top-tier quality
  • SDS
  • Datasheet
99

Mechanism of Action

Description
Bepranemab (Anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that targets to a central tau epitope (amino acids 235-250).It can be used for Alzheimer’s disease (AD) research. MW :145.92 KD.
References

Product Details

CAS No. 2244960-75-4
Isotype Human IgG4SP
Source CHO
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.